{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:53:17Z","timestamp":1792291997099,"version":"4.4.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,22]],"date-time":"2020-01-22T00:00:00Z","timestamp":1579651200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.jgar.2019.12.015","type":"journal-article","created":{"date-parts":[[2019,12,27]],"date-time":"2019-12-27T11:32:53Z","timestamp":1577446373000},"page":"87-93","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Empirical fluoroquinolones versus broad-spectrum beta-lactams for Gram-negative bloodstream infections in the absence of antimicrobial resistance risk factors"],"prefix":"10.1016","volume":"22","author":[{"given":"Majdi N.","family":"Al-Hasan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyssa P.","family":"Gould","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chelsea","family":"Drennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie Ann","family":"Justo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Kohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Brandon","family":"Bookstaver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgar.2019.12.015_bib0005","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/jac\/dkp162","article-title":"Antimicrobial resistance trends of Escherichia coli bloodstream isolates: a population-based study, 1998\u20132007","volume":"64","author":"Al-Hasan","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2019.12.015_bib0010","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1128\/AAC.00119-14","article-title":"Fluoroquinolone-resistant Escherichia coli sequence type 131 isolates causing bloodstream infections in a Canadian region with a centralized laboratory system: rapid emergence of the H30-Rx sublineage","volume":"58","author":"Peirano","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2019.12.015_bib0015","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1007\/s10096-011-1424-6","article-title":"Impact of healthcare-associated acquisition on community-onset Gram-negative bloodstream infection: a population-based study","volume":"31","author":"Al-Hasan","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jgar.2019.12.015_bib0020","doi-asserted-by":"crossref","first-page":"5918","DOI":"10.1128\/AAC.01202-13","article-title":"Optimizing empiric antibiotic therapy in patients with severe \u03b2-lactam allergy","volume":"57","author":"Koliscak","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2019.12.015_bib0025","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.ijantimicag.2016.07.013","article-title":"Effectiveness of oral antibiotics for definitive therapy of Gram-negative bloodstream infections","volume":"48","author":"Kutob","year":"2016","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jgar.2019.12.015_bib0030","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1002\/phar.2024","article-title":"Intravenous-only or intravenous transitioned to oral antimicrobials for Enterobacteriaceae-associated bacteremic urinary tract infection","volume":"37","author":"Rieger","year":"2017","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jgar.2019.12.015_bib0035","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1001\/jamainternmed.2018.6226","article-title":"Association of 30-day mortality with oral step-down vs continued intravenous therapy in patients hospitalized with Enterobacteriaceae bacteremia","volume":"179","author":"Tamma","year":"2019","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jgar.2019.12.015_bib0040","series-title":"IDWeek","article-title":"Definitive intravenous antibiotics versus oral ciprofloxacin in patients with monomicrobial Gram-negative bacteremia","author":"Cook","year":"2018"},{"key":"10.1016\/j.jgar.2019.12.015_bib0045","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1093\/jac\/dkn514","article-title":"Analysis of 4758 Escherichia coli bacteraemia episodes: predictive factors for isolation of an antibiotic-resistant strain and their impact on the outcome","volume":"63","author":"Ortega","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2019.12.015_bib0050","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1128\/AAC.00009-11","article-title":"Identifying patients harboring extended-spectrum-\u03b2-lactamase-producing Enterobacteriaceae on hospital admission: derivation and validation of a scoring system","volume":"55","author":"Tumbarello","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2019.12.015_bib0055","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1128\/AAC.02728-15","article-title":"Prediction of fluoroquinolone resistance in Gram-negative bacteria causing bloodstream infections","volume":"60","author":"Dan","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2019.12.015_bib0060","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1017\/ice.2016.292","article-title":"Clinical risk score for prediction of extended-spectrum beta-lactamase producing Enterobacteriaceae in bloodstream isolates","volume":"38","author":"Augustine","year":"2017","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.jgar.2019.12.015_bib0065","doi-asserted-by":"crossref","first-page":"791","DOI":"10.7326\/0003-4819-137-10-200211190-00007","article-title":"Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections","volume":"137","author":"Friedman","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jgar.2019.12.015_bib0070","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ajic.2008.03.002","article-title":"CDC\/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting","volume":"36","author":"Horan","year":"2008","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.jgar.2019.12.015_bib0075","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1128\/AAC.03935-14","article-title":"Stratification of the impact of inappropriate empirical antimicrobial therapy for Gram-negative bloodstream infections by predicted prognosis","volume":"59","author":"Cain","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2019.12.015_bib0080","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.cmi.2019.05.017","article-title":"Evaluation of early clinical failure criteria for Gram-negative bloodstream infections","volume":"26","author":"Rac","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jgar.2019.12.015_bib0085","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jgar.2019.12.015_bib0090","doi-asserted-by":"crossref","first-page":"e00189","DOI":"10.1128\/AAC.00189-17","article-title":"Cumulative effect of an antimicrobial stewardship and rapid diagnostic testing bundle on early streamlining of antimicrobial therapy in Gram-negative bloodstream infections","volume":"61","author":"Bookstaver","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2019.12.015_bib0095","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1111\/1469-0691.12085","article-title":"Predictive scoring model of mortality in Gram-negative bloodstream infection","volume":"19","author":"Al-Hasan","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jgar.2019.12.015_bib0100","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1111\/1469-0691.12607","article-title":"External validation of Gram-negative bloodstream infection mortality risk score in a population-based cohort","volume":"20","author":"Al-Hasan","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jgar.2019.12.015_bib0105","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1093\/cid\/ciz535","article-title":"Resilience of the Pitt bacteremia score: three decades and counting","volume":"70","author":"Al-Hasan","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2019.12.015_bib0110","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/00003246-200202000-00012","article-title":"Discriminative power on mortality of a modified Sequential Organ Failure Assessment score for complete automatic computation in an operative intensive care unit","volume":"30","author":"Junger","year":"2002","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jgar.2019.12.015_bib0115","doi-asserted-by":"crossref","first-page":"S185","DOI":"10.1016\/0002-9343(89)90055-7","article-title":"Prospective, randomized comparison of sequential intravenous followed by oral ciprofloxacin with intravenous ceftazidime in the treatment of serious infections","volume":"87","author":"Peacock","year":"1989","journal-title":"Am J Med"},{"key":"10.1016\/j.jgar.2019.12.015_bib0120","doi-asserted-by":"crossref","first-page":"191S","DOI":"10.1016\/0002-9343(89)90056-9","article-title":"Intravenous ciprofloxacin or ceftazidime in selected infections. A prospective, randomized, controlled study","volume":"87","author":"Villavicencio","year":"1989","journal-title":"Am J Med"},{"key":"10.1016\/j.jgar.2019.12.015_bib0125","doi-asserted-by":"crossref","first-page":"e02174","DOI":"10.1128\/AAC.02174-16","article-title":"Clinical benefit of appropriate empirical fluoroquinolone therapy for adults with community-onset bacteremia in comparison with third-generation-cephalosporin therapy","volume":"61","author":"Lee","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2019.12.015_bib0130","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1093\/cid\/ciy1054","article-title":"Seven versus 14 days of antibiotic therapy for uncomplicated Gram-negative bacteremia: a non-inferiority randomized controlled trial","volume":"69","author":"Yahav","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2019.12.015_bib0135","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1128\/JCM.00181-17","article-title":"Evaluation of the Accelerate Pheno System for Fast Identification and antimicrobial susceptibility testing from positive blood cultures in bloodstream infections caused by Gram-negative pathogens","volume":"55","author":"Marschal","year":"2017","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jgar.2019.12.015_bib0140","doi-asserted-by":"crossref","first-page":"e01166","DOI":"10.1128\/JCM.01166-17","article-title":"Use of the Accelerate Pheno System for identification and antimicrobial susceptibility testing of pathogens in positive blood cultures and impact on time to results and workflow","volume":"56","author":"Charnot-Katsikas","year":"2018","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jgar.2019.12.015_bib0145","doi-asserted-by":"crossref","first-page":"e01329","DOI":"10.1128\/JCM.01329-17","article-title":"Multicenter evaluation of the Accelerate PhenoTest BC Kit for rapid identification and phenotypic antimicrobial susceptibility testing using morphokinetic cellular analysis","volume":"56","author":"Pancholi","year":"2018","journal-title":"J Clin Microbiol"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716519303297?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716519303297?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T09:55:51Z","timestamp":1761990951000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213716519303297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":29,"alternative-id":["S2213716519303297"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2019.12.015","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Empirical fluoroquinolones versus broad-spectrum beta-lactams for Gram-negative bloodstream infections in the absence of antimicrobial resistance risk factors","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2019.12.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 International Society for Antimicrobial Chemotherapy. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}